Emboline has secured $20 million for its embolic protection system, designed to minimize stroke risk associated with transcatheter aortic valve replacement procedures. The Santa Cruz, CA-based company ...

Trinity Capital (NasdaqGS:TRIN) has committed new growth capital to three MedTech companies: Neuros Medical, Emboline, and ...

Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US and Europe later this year.

Lawrenceville, Ga.-based Northside Hospital Gwinnett is the first hospital in Georgia, and the first in the U.S. outside a clinical trial, to use Emboline’s embolic protection catheter during a ...

Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures such as transcatheter aortic valve replacement (TAVR), ...

Trinity Capital, an international alternative asset manager, committed $20 million in growth capital to Emboline, a MedTech company focused on ...

SANTA CRUZ, Calif., Oct. 28, 2024 /PRNewswire/ -- Emboline, Inc., a privately held medical technology company based in Santa Cruz, CA, USA, today announced filing of a patent infringement lawsuit ...

SANTA CRUZ, Calif., Oct. 23, 2025 /PRNewswire/ -- Emboline, Inc., a leading innovator in full-body embolic protection devices for transcatheter procedures, today announced completion of patient ...

Emboline CAP(TM): new approach to eliminating aortic embolic risk, providing Complete Accessible Protection(TM) from cardiac procedural-related emboli FREMONT, CA. -- Emboline, Inc. ( www.emboline.com ...

Investors are funding Emboline Inc.’s bid to make a common heart procedure safer. Replacing heart valves has conventionally been done in open-heart surgery. A newer approach, called TAVR, enables them ...